Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy of HSP90 inhibitors with platinum-containing agents

Combination therapy of HSP90 inhibitors with platinum-containing agents

US Patent 10500193 · Granted Dec 10, 2019

Estimated economic value: $17,539,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer2022
Combination therapies comprising targeted therapeutics2022
Combination therapy for treatment of ovarian cancer2021
Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhi2016
Combination therapy of HSP90 inhibitors with BRAF inhibitors2016
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR in2015
Treating cancer with HSP90 inhibitory compounds2014